Interpace Biosciences, Inc. (IDXG): Total Assets
$33.84M
As of 2025-12-31
$34.55M
As of 2026-06-30
+28.4%
3-year compound annual growth
-5.8%
5-year compound annual growth
-6.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $33.84M | +128.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $14.79M | n/a | 2026-03-30, Balance as of period end |
| 2024-09-30 | $14.04M | n/a | 2025-03-31, Balance as of period end |
| 2024-06-30 | $12.97M | n/a | 2025-03-31, Balance as of period end |
| 2024-03-31 | $12.14M | n/a | 2025-03-31, Balance as of period end |
| 2023-12-31 | $13.12M | n/a | 2025-03-31, Balance as of period end |
| 2023-06-30 | $16.06M | n/a | 2025-03-31, Balance as of period end |
| 2023-03-31 | $15.98M | n/a | 2025-03-31, Balance as of period end |
| 2022-12-31 | $15.98M | -58.4% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $38.43M | -15.9% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $45.68M | -11.4% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $51.54M | +65.6% | 2021-04-01, Balance as of period end |
| 2018-12-31 | $31.13M | -15.0% | 2021-01-19, Balance as of period end |
| 2017-12-31 | $36.62M | +45.7% | 2021-01-19, Balance as of period end |
| 2016-12-31 | $25.14M | -61.2% | 2021-01-19, Balance as of period end |
| 2015-12-31 | $64.74M | -43.8% | 2021-01-19, Balance as of period end |
| 2014-12-31 | $115.21M | +66.8% | 2021-01-19, Balance as of period end |
| 2013-12-31 | $69.06M | -12.0% | 2015-03-05, Balance as of period end |
| 2012-12-31 | $78.45M | -30.8% | 2014-03-06, Balance as of period end |
| 2011-12-31 | $113.38M | -8.9% | 2013-03-15, Balance as of period end |
| 2010-12-31 | $124.39M | n/a | 2012-03-09, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $33.84M | +128.8% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $122.54M | 0.0% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $142.63M | -11.3% |
| Cytosorbents Corp (CTSO) | 2025-12-31 | $44.18M | -6.7% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $97.75M | +149.4% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $28.20M | +3.6% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $74.23M | +75.1% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $37.34M | +24.0% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $114.86M | +50.8% |
Compare IDXG, UTMD, RVP, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗